This inventor holds 1 USPTO granted patent. Top assignee: Baylor College of Medicine. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Surendra Dawadi and His Work on Direct Thrombin Inhibitors.
Introduction
Surendra Dawadi is an inventor associated with Baylor College of Medicine in Houston, Texas. His patent work focuses on compounds and methods intended to inhibit thrombin, a target relevant to blood clotting.
Latest Patents
Dawadi is associated with 1 patent, titled “Direct Thrombin Inhibitors and Methods of Use Thereof.” The patent describes novel direct thrombin inhibitors and methods for using them as anticoagulants. It also addresses potential applications in treating or preventing thromboembolism and bleeding or clotting disorders, as well as methods for inhibiting thrombin in cells using the described compounds and compositions.
Career Highlights
The available information highlights Dawadi’s patent contribution in the area of thrombin inhibition and anticoagulant research. His work connects chemical compounds with potential therapeutic uses involving blood clotting.
Collaborations
Dawadi is associated with Baylor College of Medicine, a Houston-based institution. The provided information does not specify additional collaborators or the details of his role there.
Conclusion
Surendra Dawadi’s patent work centers on direct thrombin inhibitors and their potential use in addressing thromboembolism and bleeding or clotting disorders.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile